声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。7月29日,康宁杰瑞宣布,HER2双特异性抗体偶联药物(ADC)JSKN003获美国FDA授予孤儿药资格,用于治疗胃癌及胃食管结合部癌(GC/GEJ)。胃癌及胃食管结合部癌(GC/GEJ)是全球第5大常见癌症。氟尿嘧啶类和铂类化疗药物是常用的一线治疗。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.